Page 51

proefschrit Van Zwam inhoud met kaft en stellingen.indd

Introduction and historical background 47 468 Briggs, A. & Sculpher, M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 13, 397-409, (1998). 469 Sonnenberg, F. A. & Beck, J. R. Markov models in medical decision making: a practical guide. Med Decis Making 13, 322-338, (1993). 470 Rouder, J. N. & Lu, J. An introduction to Bayesian hierarchical models with an application in the theory of signal detection. Psychon Bull Rev 12, 573-604, (2005). 471 Malmivaara, K., Juvela, S., Hernesniemi, J., Lappalainen, J. & Siironen, J. Health-related quality of life and cost- effectiveness of treatment in subarachnoid haemorrhage. Eur J Neurol, (2012). 472 Greving, J. P., Rinkel, G. J., Buskens, E. & Algra, A. Cost-effectiveness of preventive treatment of intracranial aneurysms: new data and uncertainties. Neurology 73, 258-265, (2009). 473 Koffijberg, H., Buskens, E. & Rinkel, G. J. Aneurysm occlusion in elderly patients with aneurysmal subarachnoid haemorrhage: a cost-utility analysis. J Neurol Neurosurg Psychiatry 82, 718-727, (2011). 474 Takao, H., Nojo, T. & Ohtomo, K. Cost-effectiveness of treatment of unruptured intracranial aneurysms in patients with a history of subarachnoid hemorrhage. Acad Radiol 15, 1126-1132, (2008). 475 Takao, H. & Nojo, T. Treatment of unruptured intracranial aneurysms: decision and cost-effectiveness analysis. Radiology 244, 755-766, (2007). 476 Johnston, S. C., Gress, D. R. & Kahn, J. G. Which unruptured cerebral aneurysms should be treated? A cost- utility analysis. Neurology 52, 1806-1815, (1999). 477 Ballet, A. C. et al. Neurosurgical and endovascular treatment of intracranial aneurysms: a cost analysis of two different strategies at the University Hospital of Bordeaux (France). Neurochirurgie 48, 419-425, (2002). 478 Brinjikji, W., Kallmes, D. F., Lanzino, G. & Cloft, H. J. Hospitalization costs for endovascular and surgical treatment of unruptured cerebral aneurysms in the United States are substantially higher than medicare payments. AJNR Am J Neuroradiol 33, 49-51, (2012). 479 Hoh, B. L., Chi, Y. Y., Dermott, M. A., Lipori, P. J. & Lewis, S. B. The effect of coiling versus clipping of ruptured and unruptured cerebral aneurysms on length of stay, hospital cost, hospital reimbursement, and surgeon reimbursement at the university of Florida. Neurosurgery 64, 614-619; discussion 619-621, (2009). 480 Javadpour, M. et al. Analysis of cost related to clinical and angiographic outcomes of aneurysm patients enrolled in the international subarachnoid aneurysm trial in a North American setting. Neurosurgery 56, 886- 894; discussion 886-894, (2005). 481 Lawson, M. F. & Hoh, B. L. Clipping versus coiling: the total hospital cost of aneurysm treatment. World Neurosurg 73, 430-431, (2010). 482 Maud, A. et al. Cost-effectiveness analysis of endovascular versus neurosurgical treatment for ruptured intracranial aneurysms in the United States. J Neurosurg 110, 880-886, (2009). 483 Wolstenholme, J. et al. Treatment pathways, resource use, and costs of endovascular coiling versus surgical clipping after aSAH. Stroke 39, 111-119, (2008). 484 Zubair Tahir, M., Enam, S. A., Pervez Ali, R., Bhatti, A. & ul Haq, T. Cost-effectiveness of clipping vs coiling of intracranial aneurysms after subarachnoid hemorrhage in a developing country--a prospective study. Surg Neurol 72, 355-360; discussion 360-351, (2009). 485 Halkes, P. H., Wermer, M. J., Rinkel, G. J. & Buskens, E. Direct costs of surgical clipping and endovascular coiling of unruptured intracranial aneurysms. Cerebrovasc Dis 22, 40-45, (2006). 486 Bairstow, P., Dodgson, A., Linto, J. & Khangure, M. Comparison of cost and outcome of endovascular and neurosurgical procedures in the treatment of ruptured intracranial aneurysms. Australas Radiol 46, 249-251, (2002). 487 Bardach, N. S. et al. Regionalization of treatment for subarachnoid hemorrhage: a cost-utility analysis. Circulation 109, 2207-2212, (2004). 488 Bor, A. S., Koffijberg, H., Wermer, M. J. & Rinkel, G. J. Optimal screening strategy for familial intracranial aneurysms: a cost-effectiveness analysis. Neurology 74, 1671-1679, (2010). 489 Wermer, M. J., Koffijberg, H. & van der Schaaf, I. C. Effectiveness and costs of screening for aneurysms every 5 years after subarachnoid hemorrhage. Neurology 70, 2053-2062, (2008). 490 Schaafsma, J. D. et al. Cost-effectiveness of magnetic resonance angiography versus intra-arterial digital subtraction angiography to follow-up patients with coiled intracranial aneurysms. Stroke 41, 1736-1742, (2010). 491 Bossuyt, P. M. STARD statement: still room for improvement in the reporting of diagnostic accuracy studies. Radiology 248, 713-714, (2008). 492 Bossuyt, P. M. et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. AJR Am J Roentgenol 181, 51-55, (2003). 493 Hunink, M. G. & Krestin, G. P. Study design for concurrent development, assessment, and implementation of new diagnostic imaging technology. Radiology 222, 604-614, (2002).


proefschrit Van Zwam inhoud met kaft en stellingen.indd
To see the actual publication please follow the link above